Respond quickly to post-inspection letters from FDA, consultant warns
This article was originally published in RAJ Devices
Staying in communication with the compliance officer at US Food and Drug Administration district offices is essential when device companies receive a 483 form from the agency following an inspection. “The compliance officer is the key contact who you want to work with, and within the right timeframe, in order to avoid a warning letter,” according to Edwin Bills, principal consultant at Bilanx Consulting.
You may also be interested in...
The US healthcare reform proposals signed into law on 23 March include requirements on medical device companies to reveal payments or gifts they make to doctors. Peter Rixon takes a closer look at what the reforms’ “sunshine” provisions actually mean
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in early May.
Compliance, approvals, inspections and many other burning issues will be on the agenda of a US conference that takes place in the coming weeks.